Establishment of a mouse model of acute liver failure induced by LPS/D-GalN
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To establish a mouse model of acute liver failure induced by lipopolysaccharide/D-galactosamine (LPS/D-GalN). Methods The optimum dose of LPS/D-GalN was determined by i.p. injection of eight different doses of LPS and D-GalN into 40 female C57BL/6 mice and observation of their survival time. Then, 32 female C57BL/6 mice were i.p. injected with the optimal dose of LPS/D-GalN and sacrificed at 0, 1, 4, 8 hours after the injection, 8 mice in each group. The control mice received saline injection. Hepatic changes were observed by pathology and serum ALT, IL-6, MCP-1 and TNF-α were measured by biochemistry or flow cytometry. Results LPS (2.5 mg/kg) and D-GalN (0.3 g/kg) were determined as the optimal dose for the establishment of mouse model of acute liver injury. Compared with the control group, the hepatocellular damages were progressing in a positive correlation with the time course after LPS/D-GalN administration. The level of serum ALT was significantly increased after LPS/D-GalN administration(P<0.001). The levels of inflammatory cytokines IL-6, MCP-1 and TNF-α were increased and reached a peak at one hour after LPS/D-GalN administration and then decreased almost to that of the control group 8 hours later(P<0.001). Conclusions The mouse model of acute liver injury is successfully established by LPS/D-GalN administration, and provide an effective animal model for the study of pathogenic mechanisms of acute liver failure and evaluation of therapeutic drugs.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 21,2014
  • Revised:
  • Adopted:
  • Online: July 05,2014
  • Published: